FEMSelect Ltd.

www.femselect.com

Formerly ProAccess, POP Medical

High-Tech Company

Graduated from: RAD BioMed

TECH VERTICALS

FemTech, Gynecology, Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2012
Number of Employees	15
Employees in Israel	5
Reg. Number:	abCDe

DESCRIPTION

FEMSelect’s mission is to make a lasting impact on women’s health by delivering innovative technology for pelvic floor repair that is simple to use, provides consistent results and significantly improves outcomes for women. The company's first device is a minimally-invasive and mesh-free approach for pelvic floor ligament fixation.

TECHNOLOGY

FEMSelect is a developer of a minimally invasive uterine prolapse system. The company's product, EnPlace, is a surgical system for suturing ligaments of the pelvic floor for Pelvic Organ Prolapse (POP), and is a combination of a nitinol-based anchor and surgical sutures.

Products and Phases

Product	Phase
EnPlace	FDA Approved CE Approved 510(k) Clearance, AMAR
The EnPlace device is composed of two main elements: an anchor unit and a delivery system. The delivery system enables the guidance, insertion and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the ligament to provide pelvic floor stabilization. The EnPlace is a device, that is meshless and minimally-invasive and may be used in a procedure to address prolapse.
EnPlace	FDA Approved CE Approved 510(k) Clearance, AMAR
EnPlace is a minimally-invasive and mesh-free system for pelvic floor ligament fixation. The device is composed of two main elements: an anchor unit and a delivery system; the delivery system enables the guidance, insertion and deployment of the anchor unit; and the anchor is designed to be introduced through the vaginal wall and secured to the ligament to provide pelvic floor stabilization. EnPlace meshless and minimally-invasive and may be used in a procedure to address prolapse.

	TARGET MARKETS
	Patients with Pelvic Organ Prolapse, Women.

	BUSINESS MODEL
	B2B

COMPETITORS

Boston Scientific Corp. , Coloplast Corp , Caldera Medical , Serag Wiessner

CONTACT INFO

Expand / Collapse All

Main Address: Modiin-Maccabim-Reut, Israel

Address	2 Hamaayan St., 1st Floor
City	Modiin-Maccabim-Reut
Country	Israel
Zip	7177871

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: New York, United States

Address	521 Fifth Ave.
City	New York
State/Province	NY
Country	United States
Zip	10175

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Ms. Sasha Elizabeth Schrode	CEO
Ms. Renee Selman	Co-CEO
Ms. Deborah Slotnick-Garner	President	Avalere Health (EMEA Regional Director)
Mr. Joel Chechik	CCO
Mr. Sherwyn Davidson	VP, Quality & Regulatory Affairs	Rafael Medical (VP, Quality Management)
Mr. Boaz Harari	Co-Founder	Vectorious (Director of Mechanic Engineering)
Prof. Menahem Neuman	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	President, FEMSelect
abC Defghij	Board Member	Managing Partner & Co-Founder, Triventures
abC Defghij	Executive Chairman	Co-CEO, FEMSelect
abC Defghij	Board Member	CFO, Triventures
abC Defghij	Board Member	CEO & Managing Partner & Founder, New Age Ventures
abC Defghij	Board Member	CEO, Contura International
abC Defghij	Board Member	CEO, FEMSelect

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round

Oct. 19, 2022

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

First Round

Feb. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

Seed

Dec. 01, 2012

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Oct. 18, 2016

R&D

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

	Acquisitions made by FEMSelect

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	N/A	Jan. 01, 2012	abCDe	FemSelect acquired the IP from ProAccess.

Last Updated:	abCDe
IVC Number:	abCDe